Standex International (SXI)
(Delayed Data from NYSE)
$179.50 USD
+3.49 (1.98%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $179.77 +0.27 (0.15%) 5:00 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$179.50 USD
+3.49 (1.98%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $179.77 +0.27 (0.15%) 5:00 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Zacks News
Middleby's Deutsche Beverage Buyout to Aid Beverage Business
by Zacks Equity Research
Middleby's (MIDD) Deutsche Beverage buyout is likely to expand product offerings in the beverage platform. It will complement the company's June 2019 acquisition of Ss Brewtech.
Standex International (SXI) Beats Q2 Earnings Estimates
by Zacks Equity Research
Standex (SXI) delivered earnings and revenue surprises of 5.10% and -0.27%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Standex International (SXI) to Report Q2 Results: What to Know Ahead of the Release
by Zacks Equity Research
Standex (SXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why it is Worth Investing in Brady (BRC) Stock Now
by Zacks Equity Research
Brady (BRC) is likely to gain from product offerings, improved efficiency in manufacturing facilities and investments to expand capacity. Also, its shareholder-friendly policies enhance its attractiveness.
Colfax (CFX) Benefits From Acquired Assets Despite Costs Woes
by Zacks Equity Research
Colfax (CFX) is likely to gain from acquired assets, healthy medical technology business and emerging market exposure. High costs, forex woes and huge debts are concerns.
Here's Why it is Worth Investing in Cintas (CTAS) Stock Now
by Zacks Equity Research
Cintas (CTAS) is likely to gain from solid customer base, product portfolio, investment in technology and synergistic gains from acquired assets. Also, its shareholder-friendly policies bode well.
Cintas (CTAS) Beats Q2 Earnings & Sales Estimates, Ups View
by Zacks Equity Research
Cintas' (CTAS) second-quarter fiscal 2020 results gain from solid segmental performance and margin improvement. The company ups revenue and earnings projections for fiscal 2020.
Berry Global Group Prices Senior Secured Notes Offering
by Zacks Equity Research
Berry Global Group (BERY) prices first-priority senior secured notes offering. It intends to use net proceeds for repaying existing term loans and certain expenses of the issuer, Berry Global.
Nordson's (NDSN) Q4 Earnings Surpass Estimates, Rise Y/Y
by Zacks Equity Research
Nordson's (NDSN) fourth-quarter fiscal 2019 earnings increase year over year on account of rise of sales.
Berry Global Group's (BERY) Unit to Issue Senior Secured Notes
by Zacks Equity Research
Berry Global Group's (BERY) wholly-owned subsidiary to begin senior secured notes offering. It intends to use net proceeds for repaying existing term loans and certain expenses of the issuer.
Softness in End Markets and Forex Woes to Hurt Xylem (XYL)
by Zacks Equity Research
Xylem's (XYL) 2019 performance will likely suffer from softness in certain end markets and unfavorable movements in foreign currencies. High costs and huge debts are other concerns.
Here's Why Investors Should Steer Clear of Emerson (EMR) (Revised)
by Zacks Equity Research
Challenges in the global manufacturing market, high costs and woes related to international operations hurt Emerson (EMR).
Graco's Board Okays 9.4% Hike in Quarterly Dividend Rate
by Zacks Equity Research
Graco (GGG) to reward shareholders with a 9.4% hike in the quarterly dividend rate. This reflects its strong cash position.
EnerSys to Offer Senior Notes, Use Proceeds For Debt Repayment
by Zacks Equity Research
EnerSys (ENS) proposes private offerings of $300 million of senior notes. The proceeds will be used for the repayment of borrowings under the company's existing revolving credit facility.
Here's Why Investors Should Steer Clear of Emerson (EMR)
by Zacks Equity Research
Challenges in the global manufacturing market, high costs and woes related to international operations hurt Emerson (EMR).
Tetra Tech Wins $45M Five-Year Contract From Federal Client
by Zacks Equity Research
Tetra Tech (TTEK) gains from contracts received from government agencies. The architect-engineer contract from TAM will help the company strengthen business in the Middle East.
Donaldson (DCI) Q1 Earnings & Sales Lag Estimates, Down Y/Y
by Zacks Equity Research
Donaldson's (DCI) earnings in first-quarter fiscal 2020 decline year over year on lower sales and weak operating margin.
Middleby (MIDD) Acquires Synesso, Boosts Product Portfolio
by Zacks Equity Research
Middleby's (MIDD) Synesso buyout is likely to expand product offerings in the beverage and coffee platform.
Standex's (SXI) Torotel Buyout to Boost Magnetics Business
by Zacks Equity Research
Standex's (SXI) Torotel buyout is likely to strengthen the magnetic business and in turn, slightly boost earnings per share in the first year of the transaction completion.
Graco (GGG) Suffers From Macro Uncertainties & Margin Woes
by Zacks Equity Research
Challenging macro conditions, high costs and other margin-related issues, and forex woes hurt Graco (GGG).
Here's Why Investors Should Steer Clear of iRobot (IRBT)
by Zacks Equity Research
iRobot (IRBT) suffers from trade tensions between the United States and China, higher tariff rates, pricing actions, and adverse impacts of high promotional costs.
Rexnord Gains From Healthy Segmental Business Despite Risks
by Zacks Equity Research
Rexnord (RXN) gains from healthy operating conditions in the Water Management, and Process & Motion Control segments. It faces headwinds from softness in Europe and slowdown in the process industry.
Here's Why it is Worth Holding on to Middleby (MIDD) Stock Now
by Zacks Equity Research
Middleby (MIDD) benefits from favorable segmental operating conditions, acquired assets and focus on growth markets. However, cost and international market-related woes are affecting the company.
Middleby (MIDD) Fortifies Portfolio With Brava Home Buyout
by Zacks Equity Research
Middleby's (MIDD) Brava Home buyout is likely to expand product offerings in the commercial and residential markets.
Here's Why Casella Waste (CWST) is an Attractive Stock to Own
by Zacks Equity Research
Casella Waste (CWST) is likely to gain from solid demand, effective pricing and acquired assets. It focuses on improving landfill returns, collection profitability and technological capabilities.